Research peptide
Cagrilintide
5 mg
Select size
$65.00CAD
Volume pricing
- Buy 2Save 5%$123.50 ($61.75 each)
- Buy 3Save 10%$175.50 ($58.50 each)
Applies to the total quantity in your cart.
Research material
Supplied in a sealed glass vial and labelled with a batch reference. Batch-specific documentation is available on request. For Research Use Only. Not for Human or Animal Use.
- Presentation
- 5 mg · 10 mg
- Container
- Sealed glass vial
- Batch reference
- Printed on every unit
- Documentation
- Batch-specific COA on request
- Research use
- For Research Use Only
Description
Cagrilintide is an investigational, long-acting amylin analogue and dual amylin/calcitonin receptor agonist (DACRA) being studied for its role in appetite regulation, satiety, metabolic signaling and body-weight management.
Cagrilintide operates primarily through the amylin pathway, providing a mechanism distinct from incretin-based compounds such as GLP-1 receptor agonists. Research has focused on its ability to influence appetite, food intake, gastric emptying and satiety signaling, making the amylin pathway an important area of investigation in metabolic research.
A key area of current research is combination therapy with Semaglutide, where complementary amylin and GLP-1 receptor pathways are being investigated for their potential effects on weight management and metabolic health. This combination approach is distinct from single-pathway GLP-1 therapies and reflects growing interest in multi-pathway metabolic research.
At Kinetus Biolabs, Cagrilintide is positioned as a research compound of interest for investigating amylin biology, appetite and satiety signaling, metabolic pathways and energy-balance regulation.
Kinetus Biolabs | Precision Science. Peak Potential.
Research Use Only — Not for Human Consumption.
